Identification and Classification of Novel Genetic Variants: En Route to the Diagnosis of Primary Ciliary Dyskinesia
Autor: | Anita Skakic, Predrag Minic, Maja Stojiljkovic, Aleksandar Sovtic, Sonja Pavlovic, Nina Stevanovic, Marina Andjelkovic |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
Genetic Markers
Candidate gene QH301-705.5 In silico DNAI1 SPAG16 Computational biology Biology Article Catalysis functional analysis Inorganic Chemistry 03 medical and health sciences 0302 clinical medicine medicine otorhinolaryngologic diseases Humans Biology (General) Physical and Theoretical Chemistry QD1-999 Molecular Biology Gene Spectroscopy 030304 developmental biology Primary ciliary dyskinesia 0303 health sciences Organic Chemistry Inheritance (genetic algorithm) High-Throughput Nucleotide Sequencing Axonemal Dyneins General Medicine medicine.disease PCD in silico structural analysis 3. Good health Computer Science Applications Chemistry 030228 respiratory system Case-Control Studies NGS Mutation Motile cilium Identification (biology) Microtubule-Associated Proteins Function (biology) Ciliary Motility Disorders |
Zdroj: | International Journal of Molecular Sciences Volume 22 Issue 16 International Journal of Molecular Sciences, Vol 22, Iss 8821, p 8821 (2021) |
ISSN: | 1422-0067 |
DOI: | 10.3390/ijms22168821 |
Popis: | Primary ciliary dyskinesia (PCD) is a disease caused by impaired function of motile cilia. PCD mainly affects the lungs and reproductive organs. Inheritance is autosomal recessive and X-linked. PCD patients have diverse clinical manifestations, thus making the establishment of proper diagnosis challenging. The utility of next-generation sequencing (NGS) technology for diagnostic purposes allows for better understanding of the PCD genetic background. However, identification of specific disease-causing variants is difficult. The main aim of this study was to create a unique guideline that will enable the standardization of the assessment of novel genetic variants within PCD-associated genes. The designed pipeline consists of three main steps: (1) sequencing, detection, and identification of genes/variants (2) classification of variants according to their effect and (3) variant characterization using in silico structural and functional analysis. The pipeline was validated through the analysis of the variants detected in a well-known PCD disease-causing gene (DNAI1) and the novel candidate gene (SPAG16). The application of this pipeline resulted in identification of potential disease-causing variants, as well as validation of the variants pathogenicity, through their analysis on transcriptional, translational, and posttranslational levels. The application of this pipeline leads to the confirmation of PCD diagnosis and enables a shift from candidate to PCD disease-causing gene. |
Databáze: | OpenAIRE |
Externí odkaz: |